Question 1

What are the potential side effects of golidocitinib and the CHOP regimen?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Go-CHOP as the Frontline Therapy for PTCL clinical trial (NCT05963347). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for PTCL?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Go-CHOP as the Frontline Therapy for PTCL clinical trial (NCT05963347). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Go-CHOP as the Frontline Therapy for PTCL clinical trial (NCT05963347). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific health conditions that would prevent me from participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Go-CHOP as the Frontline Therapy for PTCL clinical trial (NCT05963347). Contact the study team or your healthcare provider for specific answers.

Question 5

What support will be available to help manage any side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Go-CHOP as the Frontline Therapy for PTCL clinical trial (NCT05963347). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Go-CHOP as the Frontline Therapy for PTCL clinical trial (NCT05963347). Contact the study team or your healthcare provider for specific answers.

What this study is about